Insider · CIK 0002104600
Jason Shand Robins
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing -, latest -.
Jason Shand Robins files SEC Form 4 as CFO at OCUL (OCULAR THERAPEUTIX, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jason Shand Robins has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +33,000 | $0.00 | $0 | 33,000 | Jan 22, 2026 |
Questions about Jason Shand Robins
Answered from the filings on this page, as of the latest one.
Is Jason Shand Robins buying or selling?
Jason Shand Robins has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jason Shand Robins's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Shand Robins has 0.
Where does Jason Shand Robins file Form 4?
Jason Shand Robins has filed Form 4 at OCUL (OCULAR THERAPEUTIX, INC) as Interim CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.